InspireMD, Inc. (NSPR) Stock Price

NSPRStock

$0.46−80.87%52W

Market Cap$21.16M

P/E—

PEG Ratio—

Div yield—

Beta0.92

NSPR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-76.19%

Price vs S&P 500 (4W)-37.98%

VGM Score56.73

Book Value / Share (Quarterly)$0.67

P/TBV (Annual)3.61x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)20.20%

Cash Flow / Share (Quarterly)$-0.90

Price vs S&P 500 (YTD)-86.35%

Gross Margin (TTM)18.05%

Net Profit Margin (TTM)-484.11%

EPS (TTM)$-0.65

10-Day Avg Trading Volume0.16M

EPS Excl Extra (TTM)$-0.65

Revenue Growth (5Y)29.24%

EPS (Annual)$-0.76

ROI (Annual)-88.38%

Gross Margin (Annual)29.50%

Net Profit Margin (5Y Avg)-402.03%

Cash / Share (Quarterly)$0.65

Revenue Growth QoQ (YoY)-0.39%

ROA (Last FY)-70.29%

Revenue Growth TTM (YoY)95.79%

EBITD / Share (TTM)$-0.65

ROE (5Y Avg)-75.66%

Operating Margin (TTM)-494.03%

Cash Flow / Share (Annual)$-0.84

P/B Ratio0.67x

P/B Ratio (Quarterly)1.04x

Net Income / Employee (Annual)$-384,100

EV / Revenue (TTM)0.55x

Net Interest Coverage (TTM)-69.08x

ROA (TTM)-84.31%

EPS Incl Extra (Annual)$-0.76

Current Ratio (Annual)5.74x

Quick Ratio (Quarterly)3.40x

3-Month Avg Trading Volume0.09M

52-Week Price Return-80.87%

Revenue / Employee (TTM)$85,400

Tangible BV / Share (Quarterly)$2.02

P/S Ratio (Annual)2.36x

Asset Turnover (Annual)0.13x

52-Week High$2.42

Operating Margin (5Y Avg)-412.06%

EPS Excl Extra (Annual)$-0.76

CapEx CAGR (5Y)79.18%

Tangible BV CAGR (5Y)42.11%

26-Week Price Return-66.28%

Quick Ratio (Annual)5.30x

13-Week Price Return-35.12%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)3.80x

Enterprise Value$6.01M

Revenue / Share Growth (5Y)-38.97%

Asset Turnover (TTM)0.17x

Book Value / Share Growth (5Y)-19.32%

Revenue / Employee (Annual)$70,700

Inventory Turnover (Annual)2.12x

Pretax Margin (Annual)-542.63%

Cash / Share (Annual)$1.25

3-Month Return Std Dev71.53%

Gross Margin (5Y Avg)23.69%

Net Income / Employee (TTM)$-413,200

ROE (Last FY)-88.38%

Net Interest Coverage (Annual)-11.49x

EPS Basic Excl Extra (Annual)$-0.76

Receivables Turnover (TTM)6.36x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.65

Receivables Turnover (Annual)4.80x

ROI (TTM)-107.96%

P/S Ratio (TTM)1.95x

Pretax Margin (5Y Avg)-401.17%

Revenue / Share (Annual)$0.14

Tangible BV / Share (Annual)$2.09

Price vs S&P 500 (52W)-96.41%

Year-to-Date Return-74.43%

5-Day Price Return-7.40%

EPS Normalized (Annual)$-0.76

ROA (5Y Avg)-58.61%

Net Profit Margin (Annual)-543.33%

Month-to-Date Return-31.84%

Cash Flow / Share (TTM)$-0.79

EBITD / Share (Annual)$-0.76

Operating Margin (Annual)-552.56%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-75.66%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.65

P/TBV (Quarterly)1.45x

P/B Ratio (Annual)1.37x

Inventory Turnover (TTM)3.09x

Pretax Margin (TTM)-483.53%

Book Value / Share (Annual)$1.27

Price vs S&P 500 (13W)-37.81%

Beta0.92x

Revenue / Share (TTM)$0.13

ROE (TTM)-107.96%

52-Week Low$0.45

vGradeA

gGradeB

mGradeF

vgmGradeC

NSPR Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 14, 2026	-$0.20	-$0.17	+15.00%(+$0.03)
Q1 2026	May 4, 2026	-$0.18	-$0.16	+11.11%(+$0.02)
Q4 2025	Mar 18, 2026	-$0.19	-$0.14	+27.58%(+$0.05)
Q3 2025	Nov 4, 2025	-$0.20	-$0.17	+12.82%(+$0.02)
Q2 2025	Aug 4, 2025	-$0.26	-$0.26	+0.00%(+$0.00)

NSPR Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.11

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
NSPRInspireMD, Inc.	A	B	F	2.0x	29.2%	18.1%	-494.0%	$0.46
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About InspireMD, Inc.

InspireMD is a U.S.-based medical device company specializing in proprietary MicroNet stent platform technology for treating complex vascular and coronary disease. Its primary revenue driver is the CGuard carotid Embolic Prevention System, which combines the company's proprietary MicroNet technology with a self-expandable stent for carotid artery applications. The company also offers the MGuard Prime Embolic Protection System and maintains operations across Europe and Russia.

NSPR Next Earnings Report

Report dateNov 10, 2026

QuarterQ3 2026

Report timeBMO

EPS estimate-$0.15

Revenue estimate$2.00M

Also reporting on Nov 10, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

BCHTBirchtech Corp.Measuring & Controlling Devices
MLSSMilestone Scientific, Inc. Common StockOrthopedic & Prosthetic Devices
ITOCiTonic Holdings Ltd Class A Ordinary SharesElectromedical Equipment
DAIOData I/O CorpInstruments for Measuring
LFWDLifeward Ltd. Ordinary SharesOrthopedic & Prosthetic Devices
CLIRClearSign Technologies Corporation Common Stock (DE)Industrial Instruments
BNGOBionano Genomics, Inc. Common StockLab Analytical Instruments
IRIXIridex CorpElectromedical Equipment

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$0.45

High$2.42